-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) Misses Q1 EPS by 3c
-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) PT Raised to $38 at BTIG
-
-
-
-
-
-
-
Denali Therapeutics to present data on enzyme therapies at medical conference
-
-
-
-
-
-
-
Denali Therapeutics secures $275 million royalty deal with Royalty Pharma
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Denali Therapeutics Inc. (DNLI)
-
-
-
-
-
-
-
FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
-
-
-
-
-
-
-
Denali Therapeutics Inc. (DNLI) PT Lowered to $80 at H.C. Wainwright
-
443,921 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

